Citigroup Maintains Buy on Omega Healthcare Invts, Raises Price Target to $58
Omega Healthcare Investors (OHI) Stock May Be 47% Undervalued Following Dividend Increase
Omega Healthcare Investors Inc's Dividend Analysis
Omega Healthcare Investors Q2 Earnings Call Highlights
Cantor Fitzgerald Maintains Overweight on Omega Healthcare Invts, Raises Price Target to $56
Omega Healthcare Investors Inc (OHI) (Q2 2026) Earnings Call Highlights: Record EBITDA Coverage ...
Omega Healthcare Investors, Inc. (OHI) Q2 2026 Earnings Call Transcript
Omega Healthcare Investors: The Silver Tsunami Now Looks Priced In (Rating Downgrade)
Omega Healthcare Investors (OHI) Q2 FFO and Revenues Beat Estimates
Omega Healthcare Investors (NYSE:OHI) Beats Q2 Estimates, Raises Full-Year Guidance
Omega Reports Second Quarter 2026 Results and Recent Developments
Omega Healthcare Invts Raises FY2026 FFO Guidance from $3.19-$3.25 to $3.22-$3.26 vs $3.23 Est
Omega Healthcare Invts Q2 FFO $0.83 Beats $0.80 Estimate, Sales $328.246M Beat $301.280M Estimate
Omega Announces Increase in Quarterly Dividend
Omega Healthcare Investors Increases Quarterly Cash Dividend From $0.67 To $0.68 Per Share
GLPI vs. OHI: Which Stock Is the Better Value Option?
Omega Healthcare: Structurally Advantaged With A Near 6% Yield
Omega Healthcare Investors (OHI) Upgraded to Buy: Here's What You Should Know
Barclays Initiates Coverage of Omega Healthcare Investors (OHI) with Underweight Recommendation
Barclays Initiates Coverage On Omega Healthcare Invts with Underweight Rating, Announces Price Target of $51
Sign up for free to unlock this feature.
Creating your account...
Your account has been created. Redirecting...
Loading...
This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.